InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.039 0.003 (7.14%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Annual Report 9 Oct 2026 11:40AM $0.041 $0.039 fallen by 4.88%
$31 Appendix 4G and Corporate Governance Statement 9 Oct 2026 11:37AM $0.041 $0.039 fallen by 4.88%
$31 Letter to Shareholders - Notice of Annual General Meeting 9 Oct 2026 11:35AM $0.041 $0.039 fallen by 4.88%
$31 Notice of Annual General Meeting/Proxy Form 9 Oct 2026 11:34AM $0.041 $0.039 fallen by 4.88%
$31 Retirement of Non-Executive Director 9 Oct 2026 11:31AM $0.041 $0.039 fallen by 4.88%
$31 Webinar with Former Secretary of Veterans Affairs Dr Shulkin 6 Oct 2026 9:36AM $0.044 $0.039 fallen by 11.36%
$31 Notification of cessation of securities - EMD 6 Oct 2026 9:32AM $0.044 $0.039 fallen by 11.36%
$31 Emyria Successfully Opens First NSW Empax Clinic 29 Sep 2026 9:03AM $0.047 $0.039 fallen by 17.02%
$31 Application for quotation of securities - EMD 25 Sep 2026 8:10AM $0.051 $0.039 fallen by 23.53%
$31 Former US Veterans Affairs Secretary Joins Emyria 21 Sep 2026 9:12AM $0.050 $0.039 fallen by 22%
$31 Emyria Presentation at FDA Hearing 16 Sep 2026 9:15AM $0.052 $0.039 fallen by 25%
$31 FDA Selects EMD to Present at Psychedelic Medicines Hearing 10 Sep 2026 9:35AM $0.048 $0.039 fallen by 18.75%
$31 Emyria Set to Launch First NSW Clinic 8 Sep 2026 8:23AM $0.046 $0.039 fallen by 15.22%
$31 Emyria Year End Presentation for Investor Webinar 8 Sep 2026 8:13AM $0.046 $0.039 fallen by 15.22%
$31 Emyria Financial Year-end Update Webinar 7 Sep 2026 9:05AM $0.044 $0.039 fallen by 11.36%
$31 Revised Securities Trading Policy 7 Sep 2026 9:03AM $0.044 $0.039 fallen by 11.36%
$31 Appendix 4E & Annual Financial Report Year End 30 June 2026 31 Aug 2026 6:38PM $0.045 $0.039 fallen by 13.33%
$31 2026 Annual General Meeting - Key Dates 31 Aug 2026 6:20PM $0.045 $0.039 fallen by 13.33%
$31 Emyria Unlocks Treatment Capacity 20 Aug 2026 9:11AM $0.044 $0.039 fallen by 11.36%
$31 Notification of cessation of securities - EMD 17 Aug 2026 8:05AM $0.047 $0.039 fallen by 17.02%
$31 Change of Registered Office and Principal Place of Business 10 Aug 2026 9:57AM $0.047 $0.039 fallen by 17.02%
$31 June 2026 Quarterly Activities Report and Appendix 4C 29 Jul 2026 9:10AM $0.048 $0.039 fallen by 18.75%
$31 June 2026 Quarterly Investor Webinar 29 Jul 2026 9:06AM $0.048 $0.039 fallen by 18.75%
$31 Techknow Invest Roadshow Company Presentation 27 Jul 2026 9:25AM $0.044 $0.039 fallen by 11.36%
$31 EMD to Present at Addressing the Mental Health Crisis Event 22 Jul 2026 8:41AM $0.047 $0.039 fallen by 17.02%

1 - 25 of 573 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.